Emerging data from human studies suggest that inhibiting the function of FABP4 may be a potential mechanism for the prevention of metabolic diseases like type 2 diabetes and atherosclerosis(37,38). This evidence concerns the gene FABP4 and type 2 diabetes mellitus.